How should a ferritin level of 7.2 ng/mL be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Ferritin 7.2 ng/mL

A ferritin of 7.2 ng/mL represents severe iron deficiency that requires immediate iron replacement therapy and gastrointestinal evaluation to identify the underlying cause. 1

Diagnostic Confirmation

This ferritin level is well below any diagnostic threshold for iron deficiency. The 2020 AGA guidelines establish that ferritin <45 ng/mL has 85% sensitivity and 92% specificity for iron deficiency, while even the older threshold of <15 ng/mL has 99% specificity 1. Your patient's level of 7.2 ng/mL is unequivocally diagnostic—this represents depleted iron stores with active iron-deficient erythropoiesis 2.

Immediate Management Steps

1. Initiate Iron Replacement

Start oral iron supplementation immediately 3:

  • Ferrous sulfate, ferrous fumarate, or ferrous gluconate are reasonable first-line choices (least expensive)
  • Take on an empty stomach when possible for better absorption
  • If not tolerated, take with meals (preferably with meat protein)
  • Add 500 mg vitamin C to enhance absorption even with food 3

Consider intravenous iron if:

  • Severe symptoms are present
  • Oral iron is not tolerated
  • Conditions exist that impair absorption (celiac disease, inflammatory bowel disease, H. pylori infection)
  • Rapid repletion is needed 3

2. Gastrointestinal Evaluation

For postmenopausal women and men: The AGA strongly recommends bidirectional endoscopy (both EGD and colonoscopy) performed at the same setting 1. This is a strong recommendation with moderate-quality evidence, as gastrointestinal blood loss is the most common cause in these populations.

For premenopausal women: First assess menstrual blood loss and dietary intake before proceeding to endoscopy, unless alarm symptoms are present.

3. Additional Workup

Evaluate for:

  • Dietary iron intake (vegetarian/vegan diet, inadequate meat consumption)
  • Menstrual history in premenopausal women
  • Helicobacter pylori infection (can impair iron absorption)
  • Celiac disease (tissue transglutaminase antibodies)
  • Inflammatory bowel disease
  • Chronic blood loss (NSAIDs, anticoagulants, occult bleeding) 3

Treatment Targets

Goal ferritin levels:

  • Normalize to >100 ng/mL in most conditions 4
  • The 2024 AGA update recommends ferritin 45-100 ng/mL as adequate for most patients 3
  • Hemoglobin target: 10-12 g/dL or normalization 4

Critical Pitfalls to Avoid

  1. Do not delay gastrointestinal evaluation while treating with iron—the underlying cause must be identified, particularly in postmenopausal women and men where malignancy is a concern 1

  2. Do not use ferritin alone in inflammatory conditions—if C-reactive protein is elevated or chronic disease is present, add transferrin saturation (<20% suggests true iron deficiency) or soluble transferrin receptor 1, 3

  3. Do not assume dietary deficiency alone in postmenopausal women or men—gastrointestinal pathology must be excluded 1

  4. Monitor response to therapy—recheck ferritin and hemoglobin in 4-8 weeks. Failure to respond suggests ongoing blood loss, malabsorption, or need for IV iron 3

Special Considerations

If celiac disease is diagnosed, ensure strict gluten-free diet adherence before expecting improvement in iron absorption 3. If small bowel bleeding is suspected after negative bidirectional endoscopy, deep enteroscopy with distal attachment should be performed to detect and treat angioectasias 3.

The severity of this ferritin level (7.2 ng/mL) indicates this patient has progressed beyond simple depletion to active impairment of red blood cell production, making both diagnosis of the underlying cause and aggressive iron repletion urgent priorities.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.